Regulatory T cells in cancer immunotherapy

Tanaka, Atsushi, Sakaguchi, Shimon·2017·Cell Research

DOI 10.1038/cr.2016.151

Cited by (1,001)

Items 301–400 of 1,001

Immunological nanomaterials to combat cancer metastasis
Yuanbo Pan, Junjie Cheng, Yang Zhu, Jianmin Zhang, Wenpei Fan, Xiaoyuan Shawn Chen · 2024 · Chemical Society Reviews
Recent advances in polysaccharide-based drug delivery systems for cancer therapy: a comprehensive review
Chou‐Yi Hsu, Omer Qutaiba B. Allela, Ali M. Hussein, Mohammed Ahmed Mustafa, Mandeep Kaur, Mohd Alaraj, Ali Fawzi Al-Hussainy, Usama Kadem Radi, Mohammed Ubaid, Ameer Hassan Idan et al. · 2024 · Artificial Cells Nanomedicine and Biotechnology
Revolutionary Cancer Therapy for Personalization and Improved Efficacy: Strategies to Overcome Resistance to Immune Checkpoint Inhibitor Therapy
Saud Almawash · 2025 · Cancers
IL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model
Kailing Wang, Shan Shan, Zongjun Yang, Xia Gu, Yuanyuan Wang, Chunhong Wang, Tao Ren · 2017 · Oncotarget
Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis
Rajiv Kumar, Shashi Bhushan Chauhan, Susanna S. Ng, Shyam Sundar, Christian R. Engwerda · 2017 · Frontiers in Immunology
Combination Immunotherapy: Taking Cancer Vaccines to the Next Level
Jeremy M. Grenier, Stephen T. Yeung, Kamal Mohan Khanna · 2018 · Frontiers in Immunology
CCL22 Signaling in the Tumor Environment
Natascha Röhrle, Maximilian M. L. Knott, David Anz · 2020 · Advances in experimental medicine and biology
Control of foreign Ag‐specific Ab responses by Treg and Tfr
James B. Wing, Ee Lyn Lim, Shimon Sakaguchi · 2020 · Immunological Reviews
Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective
Ying Li, Shuai Xiang, Wenjun Pan, Jing Wang, Hanxiang Zhan, Shanglong Liu · 2023 · Frontiers in Oncology
FAM family gene prediction model reveals heterogeneity, stemness and immune microenvironment of UCEC
Hao Chi, Xinrui Gao, Zhijia Xia, Wanying Yu, Xisheng Yin, Yifan Pan, Gaoge Peng, Xinrui Mao, Alexander Tobias Teichmann, Jing Zhang et al. · 2023 · Frontiers in Molecular Biosciences
Radioimmunotherapy in colorectal cancer treatment: present and future
Jingyi Shi, Zhuang Sun, Zhaoya Gao, Dandan Huang, Haopeng Hong, Jin Fa Gu · 2023 · Frontiers in Immunology
Transcriptional control of pancreatic cancer immunosuppression by metabolic enzyme CD73 in a tumor-autonomous and -autocrine manner
Tianyu Tang, Xing Huang, Minghao Lu, Gang Zhang, Xu Han, Tingbo Liang · 2023 · Nature Communications
CD3xPDL1 bi-specific T cell engager (BiTE) simultaneously activates T cells and NKT cells, kills PDL1+ tumor cells, and extends the survival of tumor-bearing humanized mice
Lucas A. Horn, Nicholas G. Ciavattone, Ryan S. Atkinson, Netsanet Woldergerima, Julia Wolf, Virginia K. Clements, Pratima Sinha, Munanchu Poudel, Suzanne Ostrand‐Rosenberg · 2017 · Oncotarget
CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer
Tao Wang, Quan Zhou, Han Zeng, Hongyu Zhang, Zhaopei Liu, Jialiang Shao, Zewei Wang, Ying Xiong, Jiajun Wang, Qi Bai et al. · 2020 · Cancer Immunology Immunotherapy
Turning the Tide Against Regulatory T Cells
SeongJun Han, Aras Toker, Zhe Qi Liu, Pamela S. Ohashi · 2019 · Frontiers in Oncology
Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease
Naomi Richardson, Grace E. Wootton, Amber G. Bozward, Ye Htun Oo · 2022 · Seminars in Immunopathology
Histone Deacetylation Inhibitors as Modulators of Regulatory T Cells
Andreas von Knethen, Ulrike Heinicke, Andreas Weigert, Kai D. Zacharowski, Bernhard Brüne · 2020 · International Journal of Molecular Sciences
The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star
Ruizhe Zhu, Gang Yang, Zhe Cao, Kexin Shen, Lianfang Zheng, Jianchun Xiao, Lei You, Taiping Zhang · 2020 · Therapeutic Advances in Medical Oncology
Regulation of tumor microenvironment for pancreatic cancer therapy
Xu Huang, Lei Ding, Xingkai Liu, Rongsheng Tong, Jianxun Ding, Zhiyong Qian, Lulu Cai, Ping Zhang, Di Li · 2021 · Biomaterials
Treg: A Promising Immunotherapeutic Target in Oral Diseases
Yujing Zhang, Jihua Guo, Rong Liang Jia · 2021 · Frontiers in Immunology
The impacts of zanubrutinib on immune cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
Yi‐Xin Zou, Huayuan Zhu, Xiao‐Tong Li, Yi Xia, Kourong Miao, Si‐Shu Zhao, Yujie Wu, Li Wang, Wei Xu, Jianyong Li · 2019 · Hematological Oncology
Targeting regulatory T cells for immunotherapy in melanoma
Lili Huang, Yeye Guo, Shujing Liu, Huaishan Wang, Jinjin Zhu, Lingling Ou, Xiaowei Xu · 2021 · Molecular Biomedicine
Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal
Zhenqing Wang, Liang Chen, Yiqun Ma, Xilei Li, Annan Hu, Wenxing Wang, Wenxing Wang, Xiaomin Li, Bo Tian, Jian Dong · 2021 · Journal of Nanobiotechnology
Advanced Biomaterials for Cell‐Specific Modulation and Restore of Cancer Immunotherapy
Shaobo Ruan, Yuanyu Huang, Mei He, Huile Gao · 2022 · Advanced Science
FOXP3+ regulatory T cells and the immune escape in solid tumours
Yiran Qiu, Shouyu Ke, Jieqiong Chen, Zhizhen Qin, Wenle Zhang, Yaqin Yuan, Dehua Meng, Gang Zhao, Kejin Wu, Bin Li et al. · 2022 · Frontiers in Immunology
Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers
Bo Li, Hui Chen, Shaohua Yang, Feng Chen, Liangliang Xu, Yan Li, Mingzhe Li, Chengming Zhu, Fangyuan Shao, Xinhua Zhang et al. · 2023 · Molecular Cancer
Nanoparticle-based drug delivery systems to enhance cancer immunotherapy in solid tumors
Jiaxin Zhang, Siyuan Wang, D D Zhang, Xin He, Xue Bing Wang, Huiqiong Han, Yanru Qin · 2023 · Frontiers in Immunology
Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells
Yijia Tang, Guangzu Cui, Haicong Liu, Ying Han, Changjing Cai, Ziyang Feng, Hong Shen, Shan Zeng · 2024 · 癌症：英文版
Leveraging Single-Cell Multi-Omics to Decode Tumor Microenvironment Diversity and Therapeutic Resistance
Hussein Sabit, Borros Michael Arneth, Timothy Michael Pawlik, Shaimaa E. Abdel-Ghany, Aysha Ghazy, Rawan M. Abdelazeem, Amany I. Alqosaibi, Ibtesam S. Al-Dhuayan, Jawaher Almulhim, Noof Abdulrahman Alrabiah et al. · 2025 · Pharmaceuticals
Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes
Kyohei Yugawa, Shinji Itoh, Tomoharu Yoshizumi, Norifumi Iseda, Takahiro Tomiyama, Takeo Toshima, Noboru Harada, Kenichi Kohashi, Yoshinao Oda, Masaki Mori · 2020 · Modern Pathology
Regulatory T cells expressing abundant CTLA‐4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer
Takuma Matoba, Masaki Imai, Naganari Ohkura, Daisuke Kawakita, Kei Ijichi, Tatsuya Toyama, Akimichi Morita, Shingo Murakami, Shimon Sakaguchi, Sayuri Yamazaki · 2018 · International Journal of Cancer
The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment
Yingli Guo, Yajuan Xie, Yao Luo · 2022 · Frontiers in Immunology
Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma
Hongjun Xie, Muqi Shi, Yifei Liu, Changhong Cheng, Lining Song, Zihan Ding, Huanzhi Jin, Xiaohong Cui, Yan Wang, Dengfu Yao et al. · 2022 · Frontiers in Immunology
Multi-Layered Mechanisms of Immunological Tolerance at the Maternal-Fetal Interface
Jin Soo Joo, Dongeun Lee, Jun Young Hong · 2024 · Immune Network
Copper homeostasis and copper-induced cell death in tumor immunity: implications for therapeutic strategies in cancer immunotherapy
Suhang Zhang, Qibo Huang, Tuo Ji, Qilin Li, Chuanyu Hu · 2024 · Biomarker Research
The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host disease
Cameron S. McDonald-Hyman, James Muller, Michael L. Loschi, Govindarajan Thangavelu, Asim Saha, Sudha Kumari, Dawn K. Reichenbach, Michelle J. Smith, Guoan Zhang, Brent H. Koehn et al. · 2018 · Journal of Clinical Investigation
Immunological differences between colorectal cancer and normal mucosa uncover a prognostically relevant immune cell profile
Katharina Strasser, Hanna Birnleitner, Andrea Beer, Dietmar Pils, Marlene C. Gerner, Klaus G. Schmetterer, Thomas Bachleitner‐Hofmann, Anton Stift, Michael M. Bergmann, Rudolf Oehler · 2018 · OncoImmunology
Regulatory T cells and M2 macrophages present diverse prognostic value in gastric cancer patients with different clinicopathologic characteristics and chemotherapy strategies
Liu, Xu, Xu, Danhua, Huang, Chen, Guo, Yixian, Wang, Shuchang, Zhu, Chunchao, Xu, Jia, Zhang, Zizhen, Shen, Yanying, Zhao, Wenyi et al. · 2019 · Journal of Translational Medicine
Runx2 Suppression by miR-342 and miR-363 Inhibits Multiple Myeloma Progression
Pramod S. Gowda, Benjamin J. Wildman, Timothy N. Trotter, Xiaoxuan Xu, Xiaoxiao Hao, Mohammad Q. Hassan, Yang Yang · 2018 · Molecular Cancer Research
Turning up a new pattern: Identification of cancer-associated fibroblast-related clusters in TNBC
Jindong Xie, Shaoquan Zheng, Yutian Zou, Yuhui Tang, Wenwen Tian, Chau‐Wei Wong, Song Wu, Xueqi Ou, Wanzhen Zhao, Manbo Cai et al. · 2022 · Frontiers in Immunology
Identification and classification of distinct surface markers of T regulatory cells
Agnieszka Węgrzyn, Anna Ewa Kedzierska, Andrzej Obojski · 2023 · Frontiers in Immunology
Targeting the metabolism of tumor-infiltrating regulatory T cells
Yiming Wang, Tianning Huang, Jian Gu, Ling Lu · 2023 · Trends in Immunology
MMP-2 Responsive Peptide Hydrogel-Based Nanoplatform for Multimodal Tumor Therapy
Qing Zhang, Wenjun Hu, Mingxue Guo, Xinyu Zhang, Qin Zhang, Fengqi Peng, Liwen Yan, Zucheng Hu, Jakkree Tangthianchaichana, Yan Shen et al. · 2024 · International Journal of Nanomedicine
Role of Treg cell subsets in cardiovascular disease pathogenesis and potential therapeutic targets
Yuanliang Xia, Di Gao, Xu Wang, Bin Liu, Xue Shan, Yunpeng Sun, Dashi Ma · 2024 · Frontiers in Immunology
Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma
Gang Ji, Qi Yang, Song Wang, Xiaolong Yan, Qiuxiang Ou, Li Gong, Jinbo Zhao, Yongan Zhou, Feng Tian, Jie Lei et al. · 2024 · Genome Medicine
A standardized flow cytometry procedure for the monitoring of regulatory T cells in clinical trials
Fabien Pitoiset, Michèle Barbié, Guillaume Monneret, Cécile Braudeau, Pierre Pochard, Isabelle Pellegrin, Jacques Trauet, Myriam Labalette, David Klatzmann, Michèlle Rosenzwajg · 2018 · Cytometry Part B Clinical Cytometry
Enhanced antitumor efficacy through microwave ablation in combination with immune checkpoints blockade in breast cancer: A pre-clinical study in a murine model
Junhao Zhu, Mengxue Yu, Lijuan Chen, P. Kong, Lingyun Li, Guannan Ma, Huimin Ge, Y. Cui, Zaiwang Li, Hong Pan et al. · 2018 · Diagnostic and Interventional Imaging
Focus on mast cells in the tumor microenvironment: Current knowledge and future directions
Saimeng Shi, Long‐Yun Ye, Xianjun Yu, Kaizhou Jin, Weiding Wu · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Impact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer
Ivan Cohen, Ronald G. Blasberg · 2017 · Breast Cancer Basic and Clinical Research
Tumor microenvironment pathways: Cross regulation in breast cancer metastasis
Rama Rao Malla, P. Janardhana Kiran · 2020 · Genes & Diseases
Pharmacologic Activation of LXR Alters the Expression Profile of Tumor-Associated Macrophages and the Abundance of Regulatory T Cells in the Tumor Microenvironment
José M. Carbó, Theresa E. León, Joan Font-Díaz, Juan Vladimir de la Rosa, Antonio Castrillo, Felix S.R. Picard, Daniel Staudenraus, Magdalena Huber, Lídia Cedó, Joan Carles Escolá‐Gil et al. · 2020 · Cancer Research
The traditional chinese medicine monomer Ailanthone improves the therapeutic efficacy of anti-PD-L1 in melanoma cells by targeting c-Jun
Pian Yu, Hui Wei, Kaixuan Li, Shiguo Zhu, Jie Li, Chao Chen, Detian Zhang, Yayun Li, Lei Zhu, Xiaoqing Yi et al. · 2022 · Journal of Experimental & Clinical Cancer Research
TUSC2 Immunogene Therapy Synergizes with Anti–PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras -Mutant Mouse Lung Cancer Models
Ismail Mustafa Meraz, Mourad Majidi, Xiaobo X. Cao, Heather Yan Lin, Lerong Li, Jing Wang, Veera Baladandayuthapani, David C. Rice, Boris Sepesi, Lin Ji et al. · 2018 · Cancer Immunology Research
The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors
Evangelos Koustas, Panagiotis Sarantis, Athanasios G. Papavassiliou, Michalis V. Karamouzis · 2020 · Biomolecules
Combination PD-1 blockade and irradiation of brain metastasis induces an effective abscopal effect in melanoma
Lukas W. Pfannenstiel, Corey McNeilly, Chaomei Xiang, Kai Kang, Claudia Marcela Diaz-Montero, Jennifer S. Yu, Brian Gastman · 2018 · OncoImmunology
OLR1 is a prognostic factor and correlated with immune infiltration in breast cancer
Xiangyu Sun, Xin Fu, Shouping Xu, Pengfei Qiu, Zhi‐Dong Lv, Mingke Cui, Qiang Zhang, Yingying Xu · 2021 · International Immunopharmacology
Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencing
Yi Bai, Dapeng Chen, Chuanliang Cheng, Zhongmin Li, Hao Chi, Yuliang Zhang, Xiaoyu Zhang, Shaohai Tang, Qiang Zhao, Yamin Zhang et al. · 2022 · Frontiers in Immunology
Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities
Feng‐Ming Tien, Hsuan‐Hsuan Lu, Shu‐Yung Lin, Hsing-Chen Tsai · 2023 · Journal of Biomedical Science
Construction and validation of a cuproptosis-related prognostic model for glioblastoma
Bohong Zhang, Lin Xie, Jiahao Liu, Anmin Liu, Ming‐Liang He · 2023 · Frontiers in Immunology
The protective and pathogenic role of Th17 cell plasticity and function in the tumor microenvironment
Yuanyuan Pan, Wenjing Yang, Bo Tang, Xiaobo Wang, Qi Zhang, Weiping Li, Li Li · 2023 · Frontiers in Immunology
Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations
Junwei Ge, Xuan Yin, Lujun Chen · 2024 · Frontiers in Immunology
Immune-cell signatures of persistent inflammation, immunosuppression, and catabolism syndrome after sepsis
Xingfeng Sun, Wen-Chen Luo, Shaoqiang Huang, Yi-Jun Zheng, Lei Xiao, Zhongwei Zhang, Ronghua Liu, Ziwen Zhong, Jieqiong Song, Ke Nan et al. · 2025 · Med
Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial
Poulam M. Patel, Christian H. H. Ottensmeier, Clive Mulatero, Paul C. Lorigan, Ruth Plummer, Hardev Pandha, Somaia Elbauomy Elsheikh, Efthymios Hadjimichael, Naty Villasanti, Sally E. Adams et al. · 2018 · OncoImmunology
IL-33 increases ST2+Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner
Elizabeth C. Halvorsen, Sarah Elizabeth Franks, Brennan J. Wadsworth, Bryant Harbourne, Rachel A. Cederberg, Catherine A. Steer, Itziar Martínez-González, Jack Calder, William Wirt Lockwood, Kevin L. Bennewith · 2018 · OncoImmunology
Ring finger protein 31–mediated atypical ubiquitination stabilizes forkhead box P3 and thereby stimulates regulatory T-cell function
Fuxiang Zhu, Gang Yi, Xu Liu, Fangming Zhu, Anna Zhao, Aiting Wang, Ruihong Zhu, Zuojia Chen, Binbin Zhao, Sijie Fang et al. · 2018 · Journal of Biological Chemistry
Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies
Shin Foong Ngiow, Arabella Young · 2020 · Frontiers in Immunology
Regulatory T-cell Transcriptomic Reprogramming Characterizes Adverse Events by Checkpoint Inhibitors in Solid Tumors
Maria Grigoriou, Aggelos Banos, Aikaterini Hatzioannou, Andreas Kloetgen, Panagiotis Kouzis, Despoina Aggouraki, Roubini Zakopoulou, Giorgos Bamias, Eva N. Kassi, Dimitriοs Mavroudis et al. · 2021 · Cancer Immunology Research
Elastic Nanovaccine Enhances Dendritic Cell‐Mediated Tumor Immunotherapy
Qiang Li, Zhaogang Teng, Jun Tao, Wenhui Shi, Guangwen Yang, Yu Zhang, Xiaodan Su, Lin Chen, Weijun Xiu, Lihui Yuwen et al. · 2022 · Small
Protective Effects of Natural Antioxidants on Inflammatory Bowel Disease: Thymol and Its Pharmacological Properties
Yao Liu, Hui Yan, Bing Yu, Jun He, Xiangbing Mao, Jie Yu, Ping Zheng, Zhiqing Huang, Yuheng Luo, Junqiu Luo et al. · 2022 · Antioxidants
The role of mitochondria in the resistance of melanoma to PD-1 inhibitors
Fei Du, Lu-han Yang, Jiao Liu, Jian Wang, Lianpeng Fan, Suwit Duangmano, Hao Liu, Minghua Liu, Jun Wang, Xiaolin Zhong et al. · 2023 · Journal of Translational Medicine
The Impact of Metformin on Tumor-Infiltrated Immune Cells: Preclinical and Clinical Studies
Mohamed Abdelmoneim, Mona Alhussein Aboalela, Yoshinori Naoe, Shigeru Matsumura, Ibrahim Ragab Eissa, Itzel Bustos‐Villalobos, Patricia Angela Sibal, Yuhei Takido, Yasuhiro Kodera, Hideki Kasuya · 2023 · International Journal of Molecular Sciences
CD155 and its receptors in cancer immune escape and immunotherapy
Ruijia Zhou, Shiyin Chen, Qiwen Wu, Lingyun Liu, Yian Wang, Yongzhen Mo, Zhaoyang Zeng, Xuyu Zu, Wei Xiong, Fuyan Wang · 2023 · Cancer Letters
The role of CD4+ T cells in tumor and chronic viral immune responses
Luoyingzi Xie, Jingyi Fang, Juncheng Yu, Weinan Zhang, Zhiqiang He, Lilin Ye, Huaizhi Wang · 2023 · MedComm
Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy
Lei Zhou, Maria Velegraki, Yi Wang, Jay K. Mandula, Yuzhou Chang, Weiwei Liu, No‐Joon Song, Hyunwoo Kwon, Tong Xiao, Chelsea M. Bolyard et al. · 2024 · Journal of Clinical Investigation
Foxp3 confers long-term efficacy of chimeric antigen receptor-T cells via metabolic reprogramming
Congyi Niu, Huan Wei, Xuanxuan Pan, Yuedi Wang, Huan Song, Congwen Li, Jingbo Qie, Jiawen Qian, Shaocong Mo, Wanwei Zheng et al. · 2025 · Cell Metabolism
Vaccination against atherosclerosis
Kouji Kobiyama, Ryosuke Saigusa, Klaus F. Ley · 2019 · Current Opinion in Immunology
T cell immunotherapy enhanced by designer biomaterials
Zachary Spencer Dunn, John Mac, Pin Wang · 2019 · Biomaterials
Regulatory T Cells Support Breast Cancer Progression by Opposing IFN-γ-Dependent Functional Reprogramming of Myeloid Cells
Nicholas M. Clark, Leandro Marcelo Martinez, Steven J. Murdock, James T. DeLigio, Amy L. Olex, Comfort Effi, Mikhail G. Dozmorov, Paula D. Bos · 2020 · Cell Reports
CD4+ T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancer
Shaochuan Liu, Yuan Guang Meng, Liang Liu, Yingge Lv, Wenwen Yu, Ting Liu, Limei Wang, Di Mu, Qiuru Zhou, Min Liu et al. · 2022 · Cell Death and Disease
Regulatory T cells converted from Th1 cells in tumors suppress cancer immunity via CD39
Sang-Nee Tan, Jing Hao, Jing Ge, Yazheng Yang, L H Liu, Huang Jia, Meng Lin, Xiaohong Zhao, Genyu Wang, Zhiying Yang et al. · 2025 · The Journal of Experimental Medicine
Regulatory T cells in retroviral infections
Kim J. Hasenkrug, Claire Anne Chougnet, Ulf Dittmer · 2018 · PLoS Pathogens
Exosomes Function in Tumor Immune Microenvironment
Yin Huang, Keli Liu, Qing Li, Yikun Yao, Ying Wang · 2018 · Advances in experimental medicine and biology
Increased CD3+ T cells with a low FOXP3+/CD8+ T cell ratio can predict anti-PD-1 therapeutic response in non-small cell lung cancer patients
Hyojin Kim, Hyun Jung Kwon, Yeon Bi Han, Soo Young Park, Eun Sun Kim, Se Hyun Kim, Yu Jung Kim, Jong Seok Lee, Jin-Haeng Chung · 2018 · Modern Pathology
Recent advances in the study of regulatory T cells in gastric cancer
Xu Liu, Zizhen Zhang, Gang Zhao · 2019 · International Immunopharmacology
Opportunities for Conventional and In Situ Cancer Vaccine Strategies and Combination with Immunotherapy for Gastrointestinal Cancers, A Review
Rachid Bouzid, Maikel Petrus Peppelenbosch, Sonja I. Buschow · 2020 · Cancers
Enhanced antitumor efficacy through microwave ablation combined with a dendritic cell-derived exosome vaccine in hepatocellular carcinoma
Xinyu Zhong, Yan Zhou, Yuting Cao, Jianmin Ding, Peng Wang, Ying Luo, Hui Liu, Zhengyan Zhu, Xiang Jing · 2020 · International Journal of Hyperthermia
Photothermal therapies to improve immune checkpoint blockade for cancer
Preethi Bala Balakrishnan, Elizabeth E. Sweeney, A. Shri Ramanujam, Rohan Fernandes · 2020 · International Journal of Hyperthermia
Optimizing the Treatment Schedule of Radiotherapy Combined With Anti-PD-1/PD-L1 Immunotherapy in Metastatic Cancers
Yuehong Kong, Yifu Ma, Xiangrong Zhao, Jie Pan, Zhi Zhong Xu, Liyuan Zhang · 2021 · Frontiers in Oncology
Profiling of immune features to predict immunotherapy efficacy
Youqiong Ye, Yongchang Zhang, Nong Yang, Qian Gao, Xinyu Ding, Xinwei Kuang, Rujuan Bao, Zhao Zhang, Chaoyang Sun, Bingying Zhou et al. · 2021 · The Innovation
Nano-drug delivery systems for T cell-based immunotherapy
Rui P. Li, Zhimin Chen, Juyi Li, Zhifei Dai, Yingjie Yu · 2022 · Nano Today
miR‐133a‐3p/FOXP3 axis regulates cell proliferation and autophagy in gastric cancer
Jia‐Peng Li, Huimin Zhang, Meijun Liu, Yuan Xiang, Hui Li, Feng Huang, Hanhan Li, Zhou‐Tong Dai, Chao Jiang Gu, Xing‐Hua Liao et al. · 2020 · Journal of Cellular Biochemistry
Immunometabolism – The Role of Branched-Chain Amino Acids
Berkay Yahsi, Gürcan Günaydın · 2022 · Frontiers in Immunology
Advances in the study of HSP70 inhibitors to enhance the sensitivity of tumor cells to radiotherapy
Sihan Du, Ying Liu, Yuan Yuan, Yuran Wang, Yanfang Chen, Shuai Wang, Yuhua Chi · 2022 · Frontiers in Cell and Developmental Biology
Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment
Rongyang Li, Bing Quan Huang, Hui Tian, Zhenguo Sun · 2023 · Frontiers in Oncology
Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy
Pooya Farhangnia, Shamim Mollazadeh Ghomi, Mahzad Akbarpour, Ali‐Akbar Delbandi · 2023 · Frontiers in Immunology
Nano-formulated delivery of active ingredients from traditional Chinese herbal medicines for cancer immunotherapy
Qi Shang, Wandong Liu, Faith Leslie, Jiapei Yang, Mingmei Guo, Mingjiao Sun, Guangji Zhang, Qiang Zhang, Feihu Wang · 2023 · Acta Pharmaceutica Sinica B
Immunocytes in the tumor microenvironment: recent updates and interconnections
Jiyao Yu, Li Fu, Rui Wu, Linyi Che, Guodong Liu, Qinwen Ran, Zhiwei Xia, Xisong Liang, Guanjian Zhao · 2025 · Frontiers in Immunology
The Role of Regulatory T Cells in Pulmonary Arterial Hypertension
Haihua Qiu, Yi He, Fan Ouyang, Ping Jiang, Shuhong Guo, Yuan Guo · 2019 · Journal of the American Heart Association
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
David König, Heinz Philipp Laubli · 2020 · Pharmacology
Tumor-Infiltrating Regulatory T-cell Accumulation in the Tumor Microenvironment Is Mediated by IL33/ST2 Signaling
Jimin Son, Jae-Won Cho, Hyo Jin Park, Jihyun Moon, Seyeon Park, Hoyoung Lee, Jeewon Lee, Gamin Kim, Su-Myeong Park, Sérgio A. Lira et al. · 2020 · Cancer Immunology Research